Oncologia Medica & Innovation

Homepage: omiweb.org

ROR: 04vmvpd11

OpenAlex ID: I4405285145

Prognostic Effect of Performance Status on Outcomes of Patients with Colorectal Cancer Receiving First-Line Chemotherapy: A Meta-analysis

2023 · Giuseppe A. Colloca, Antonella Venturino · Journal of Gastrointestinal Cancer · 11

Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial‐level analysis

2024 · Giuseppe A. Colloca, Antonella Venturino · Cancer · 4

Prognostic Effect of CEA Cut-Off in Patients with Resectable Colorectal Liver Metastases: A Meta-Analysis and Meta-Regression

2025 · Antonella Venturino, Giuseppe A. Colloca · Journal of Gastrointestinal Cancer · 3

Neutrophil-to-lymphocyte ratio in unresectable or metastatic esophageal squamous cell carcinoma: a systematic review, meta-analysis and meta-regression

2026 · Giuseppe Antonio Colloca, Antonella Venturino · Clinical & Translational Oncology · 2

Different outcomes by sex in metastatic gastrointestinal stromal tumor patients receiving imatinib: a trial-level analysis

2025 · Antonella Venturino, Giuseppe Antonio Colloca · International Journal of Clinical Oncology · 2

Outcomes and Prognostic Factors of Patients with Unresectable or Metastatic Esophageal Squamous Cell Carcinoma Undergoing Immunotherapy- Versus Chemotherapy-Based Regimens: Systematic Review and Pooled Analyses

2024 · Giuseppe A. Colloca, Antonella Venturino · Journal of Gastrointestinal Cancer · 2

The Prognosis of Metastatic Gastrointestinal Cancer

2024 · Giuseppe A. Colloca, Antonella Venturino · CRC Press eBooks · 2

Alpha-fetoprotein change after systemic treatments in advanced hepatocellular carcinoma: a systematic review and trial-level meta-analysis

2026 · Antonella Venturino, Giuseppe A. Colloca · European Journal of Gastroenterology & Hepatology

Six-month progression-free survival-related tumor growth rate after upfront chemotherapy as an outcome measure and potential prognostic or stratification variable for patients with unresectable pancreatic adenocarcinoma: an exploratory study cohorts analysis

2026 · Giuseppe A. Colloca, Antonella Venturino · Journal of Chemotherapy

Global health status time to deterioration after systemic treatments of advanced gastric cancer: a systematic review and trial-level analysis

2026 · Giuseppe A. Colloca, Antonella Venturino · Current Medical Research and Opinion

Prognostic factors and outcome measures after BRAF-directed targeted therapy of unresectable metastatic BRAFV600E colorectal cancer: a study cohort-level analysis

2026 · Giuseppe A. Colloca, Antonella Venturino · Investigational New Drugs

Maintenance therapy in patients with unresectable metastatic colorectal cancer receiving oxaliplatin plus antiangiogenic-based induction regimen: a study cohorts analysis

2025 · Giuseppe A. Colloca, Antonella Venturino · Expert Review of Anticancer Therapy

Immune Checkpoint Inhibitors Affect Post‐Progression Survival of Specific Patient Subgroups With Advanced Hepatocellular Carcinoma: A Study Cohorts' Analysis

2024 · Giuseppe A. Colloca, Antonella Venturino · Journal of Digestive Diseases

Effect of Subgroups on Study Outcomes in Unresectable Hepatocellular Carcinoma Undergoing Upfront Systemic Treatment: A Meta-analysis

2024 · Giuseppe Antonio Colloca, Antonella Venturino · American Journal of Clinical Oncology

P-193 Tumor burden-related variables in trials of metastatic colorectal cancer

2023 · G. Colloca, A. Venturino · Annals of Oncology

P-86 Hypo-albuminemia as a tumor-related prognostic factor in metastatic pancreatic adenocarcinoma

2023 · A. Venturino, G. Colloca · Annals of Oncology

Myeloid Toxicity Profile is Related to Treatment Outcome in Trials of Second-Line Hemotherapy of Patients with Metastatic Colorectal Cancer

2023 · Giuseppe Antonio Colloca, Antonella Venturino · Eurasian Journal of Medical Advances

Works count: 17

Citation count: 50